Page 13 - P4403.14_V91_YOUROTC_Book APRIL_2024_PRINT
P. 13
IN THE KNOW: ALLERGY 13
OWN BRAND 13
Allergy Brand Performance
2023
Allergy Brand Performance
Sponsored by
Despite strong growth from challenger-brand Allevia, Piri continues to dominate the allergy market,
2023
sustaining the leading market share.
Allergy Brands – Value % Share of Total Market
Total Coverage - STD w/e 05.08.23 Sponsored by
100% Despite strong growth from challenger-brand Allevia, Piri continues to dominate the allergy market,
90% sustaining the leading market share. ALL OTHER INCL. PL
33.2
ALLEVIA
35.0
80% Allergy Brands – Value % Share of Total Market
40.9
POLLENASE
70% Total Coverage - STD w/e 05.08.23 STERIMAR
100%
9.6
60% 0.2 6.0 0.0 OPTREX
-
0.1
1.0
1.0
0.9
50% 90% 9.9 9.3 8.6 GALPHARM ALL OTHER INCL. PL
BENADRYL
33.2
5.3
0.4
40% 80% 4.7 40.9 5.4 35.0 CLARITYN ALLEVIA
1.6
0.4
1.4
0.4
8.0 8.0 1.2 CLARINAZE POLLENASE
30% 1.0 0.7 8.9
70% 0.6 BECODEFENCE STERIMAR
20% BECONASE
60% 28.9 0.2 28.3 6.0 9.6 OPTREX
0.1
-
1.0
1.0
26.2
0.0
0.9
10% OTRIVINE GALPHARM
50% PIRI
0% 9.9 9.3 8.6 BENADRYL
STD 2021 STD 2022 STD 2023
STD 2YA
STD YA
STD TY
40% 4.7 5.4 5.3 CLARITYN
0.4
0.4
1.6
1.4
0.4
8.0 8.0 1.2 CLARINAZE
8.9
The Peak period continues to gain importance, accounting for 62% of the season’s sales, while the
30%
1.0
post peak period is losing importance. 0.7 0.6 BECODEFENCE
20%
Allergy – Value % Share of Allergy BECONASE
28.9
28.3
Total Coverage - STD split years by peaks w/e 05.08.2023 26.2 OTRIVINE
10%
31.5 29.2 29.3 60.9 62.6 PIRI
0% 56.8 11.7 9.9
STD 2021 STD 2022 STD 2023 8.1
STD YA
STD TY
STD 2YA
The Peak period continues to gain importance, accounting for 62% of the season’s sales, while the
post peak period is losing importance.
Pre-Peak 2YAPre-Peak YAPre-Peak TY Peak 2YA Peak YA Peak TY Post Peak Post Peak YAPost Peak TY
2YA
Buying Trade POR
Product
Size
Allergy – Value % Share of Allergy Price/ RRP Offer % Pip Code
%
Single
This year, syrup supply constraints held back growth in the Kids segment. Despite this, Piri syrups
Total Coverage - STD split years by peaks w/e 05.08.2023
PIRI
continue to dominate the Kids segment.
PIRITON SYRUP 2MG/5ML 150ml £3.37 £6.50 7% 38% 022-0392
Kids and Adults – Value and Unit Sales 500 £20.26 £38.00 60.9 36% 022-0434
31.5
62.6
PIRITON TABS 4MG
5%
29.2
29.3
Total Coverage - STD TY, YA, 2YA w/e 05.08.23 30 56.8 £5.50 8% 38% 213-2074 11.7 9.9
PIRITON TABS 4MG
£2.83
PIRITEZE SYRUP 70ml £3.26 £6.49 10% 40% 301-7993 8.1
8.5% PIRITON TABS 4MG 60 91.5% £9.50 9% 39% 333-9199
£4.85
£5.00
PIRINASE ALLERGY SPRAY 60 dose
-0.3%pts +0.3% £9.50 9% 37% 359-0320
PIRINASE HAYFEVER NASAL SPRAY 60 dose £5.00 £9.50 10% 37% 377-3173
£7.99
KIDS - Value Sales £m 14 £4.53 KIDS - Unit Sales (m) Post Peak Post Peak YAPost Peak TY
PIRITEZE ALLERGY TABS
409-3456
10% 32%
Pre-Peak 2YAPre-Peak YAPre-Peak TY Peak 2YA £13.99 10% 37% Peak TY
Peak YA
410-4691
PIRINASE ALLERGY SPRAY 120 dose
£7.35
£10.4m £10.1m 2.1m 2YA
1.8m
1.7m
£8.1m PIRI NATURALS SPRAY 100ml £4.60 £8.69 9% 36% 414-9555
This year, syrup supply constraints held back growth in the Kids segment. Despite this, Piri syrups
PIRITEZE ALLERGY RELIEF SYR 2YRS+
39%
70ml
9%
£6.49
419-9725
£3.31
continue to dominate the Kids segment.
+27.7% -2.4% +24.0% -10.7%
Kids and Adults – Value and Unit Sales
STD 2YA STD YA STD TY STD 2YA STD YA STD TY
Total Coverage - STD TY, YA, 2YA w/e 05.08.23
8.5% 91.5%
-0.3%pts +0.3%
KIDS - Value Sales £m KIDS - Unit Sales (m)
£10.4m £10.1m 2.1m
£8.1m 1.7m 1.8m
+27.7% -2.4% +24.0% -10.7%
STD 2YA STD YA STD TY STD 2YA STD YA STD TY
